The phrase "a demonstration of increased" is correct and usable in written English.
It can be used when discussing evidence or examples that show a rise or improvement in a particular area or metric.
Example: "The study provided a demonstration of increased productivity among employees who worked remotely."
Alternatives: "an indication of heightened" or "a display of enhanced".
The changes in fibre percentage were statistically significant beyond 12 weeks of treatment, and it while one could argue about the relevance of this 'fibre percentage' as a chosen end-point, it would be difficult to argue there has not been a clear demonstration of increased functional dystrophin protein in the muscle of the boys treated with eteplirsen.
These results can be regarded as a demonstration of an increased amount of the shortest chain, i.e., ClPrSH, in the DBA-SH ClPrSH mixeDBA-SH ClPrSHg supramixedular complexeSAMith increasing bylk.
As a consequence, the demonstration of increased IL-21 production in type 1 diabetes patients supports the findings from genetic studies of type 1 diabetes implicating a dysfunction of the IL-2 signalling pathway in the pathogenesis of the disease [ 20– 20].
Intact uptake of 125I-Ang(1 12) was significantly higher in SHR, a finding that agrees with the previous demonstration of increased Ang-(1 12) content in the myocardium of adult hypertensive rats by both immunohistochemistry and RIA.
An increase in the numbers of medium and large afferents in the knee, demonstrating CLR immunoreactivity, was observed following MIA, a finding that is consistent with our demonstration of increased CLR mRNA levels in MIA-treated rats.
The demonstration of increased acetylation using a simple peripheral blood mononuclear cell flow cytometry assay during the first month provides a clinically relevant biomarker for defining those most likely to benefit from the addition of panobinostat to azacitidine-based therapy.
A role for KLF5 in VSMC proliferation and our demonstration of increased expression of cell cycle genes are consistent with the known effects of KLF5 in other cells.
Further evidence that the ML38 and ML46 cells shown in Figure 1 had indeed entered a crisis phase after 38 and 54 population doublings comes from the increased number of cells with a DNA content less than 2n, a sign of apoptosis, seen in the respective panels as well as from the demonstration of increased expression levels of p21, another marker of crisis, as shown in Figure 1B for ML46.
To the best of our knowledge, this is the first demonstration of increased [11C]erlotinib uptake in NSCLC tumors harboring the L858R point mutation.
